Literature DB >> 11839422

Induction of Fos protein-like immunoreactivity in the trigeminal spinal nucleus caudalis and upper cervical cord following noxious and non-noxious mechanical stimulation of the whisker pad of the rat with an inferior alveolar nerve transection.

Hirofumi Nomura1, Akiko Ogawa, Akimasa Tashiro, Toshifumi Morimoto, James W Hu, Koichi Iwata.   

Abstract

After transection of the inferior alveolar nerve (IAN: the third branch of the trigeminal nerve), the whisker pad area, which is innervated by the second branch of the trigeminal nerve, showed hypersensitivity to mechanical stimulation. Two days after IAN transection, the threshold intensity for escape behavior to mechanical stimulation of the ipsilateral whisker pad area was less than 1.0 g, a sign of allodynia, and returned to the preoperative level (preoperative threshold: 52.0 g) at 32 days after surgery. This decrement of escape threshold lasted for more than 3 weeks. The whisker pad area contralateral to the IAN transection also showed a decrease in escape threshold to non-noxious mechanical stimulation as compared with sham-operated rats. However, the change in threshold intensity for the side contralateral to transection was not as pronounced as that on the ipsilateral side. Fos protein-like immunoreactive (LI) cells were observed in the superficial laminae but not dominant in deeper laminae of the trigeminal spinal nucleus caudalis (Vc) and the first segment of the spinal cord (C1) after non-noxious mechanical stimulation of the whisker pad area in the rats with IAN transection. Fos protein-LI cells were expressed bilaterally in the Vc and C1, but were more numerous on the ipsilateral side to transection than on the contralateral side. The largest number of Fos protein-LI cells was observed at 2400 microm caudal from the trigeminal subnucleus interporalis (Vi)-Vc border both in ipsilateral and contralateral sides. The number of Fos protein-LI cells increased after application of 1, 4, and 16 g stimuli as compared to rats without mechanical stimulation. Furthermore, an extensively greater number of Fos protein-LI cells were expressed both in superficial and deep laminae of the bilateral Vc and C1 of the spinal cord after subcutaneous injection of mustard oil into the whisker pad. Fos protein expression after mustard oil injection was much stronger than that observed after any mechanical stimulation in the rats with IAN transection. These data suggest that the change in the numbers and spatial arrangement of nociceptive neurons in the Vc and C1 after IAN transection reflect the development of mechanical hyperalgesia in the area adjacent to the IAN innervated region.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839422     DOI: 10.1016/S0304-3959(01)00403-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  21 in total

1.  Peripheral nerve injury activates convergent nociceptive input to dorsal horn neurons from neighboring intact nerve.

Authors:  Ryuji Terayama; Yuya Yamamoto; Noriko Kishimoto; Kotaro Maruhama; Masahide Mizutani; Seiji Iida; Tomosada Sugimoto
Journal:  Exp Brain Res       Date:  2015-01-20       Impact factor: 1.972

2.  Bilateral activation of glial cells and cellular distribution of the chemokine CCL2 and its receptor CCR2 in the trigeminal subnucleus caudalis of trigeminal neuropathic pain model.

Authors:  Lucie Kubíčková; Ilona Klusáková; Petr Dubový
Journal:  Histochem Cell Biol       Date:  2020-02-04       Impact factor: 4.304

3.  Differential Changes in Neuronal Excitability in the Spinal Dorsal Horn After Spinal Nerve Ligation in Rats.

Authors:  Ryuji Terayama; Yuya Yamamoto; Noriko Kishimoto; Mitsuyasu Tabata; Kotaro Maruhama; Seiji Iida; Tomosada Sugimoto
Journal:  Neurochem Res       Date:  2016-07-14       Impact factor: 3.996

4.  Activated microglia contribute to convergent nociceptive inputs to spinal dorsal horn neurons and the development of neuropathic pain.

Authors:  Yuya Yamamoto; Ryuji Terayama; Noriko Kishimoto; Kotaro Maruhama; Masahide Mizutani; Seiji Iida; Tomosada Sugimoto
Journal:  Neurochem Res       Date:  2015-03-18       Impact factor: 3.996

5.  Possible involvement of convergent nociceptive input to medullary dorsal horn neurons in intraoral hyperalgesia following peripheral nerve injury.

Authors:  Ryuji Terayama; Hiroki Tsuchiya; Shinji Omura; Kotaro Maruhama; Masahide Mizutani; Seiji Iida; Tomosada Sugimoto
Journal:  Cell Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.046

6.  Convergent nociceptive input to spinal dorsal horn neurons after peripheral nerve injury.

Authors:  Ryuji Terayama; Noriko Kishimoto; Yuya Yamamoto; Kotaro Maruhama; Hiroki Tsuchiya; Masahide Mizutani; Seiji Iida; Tomosada Sugimoto
Journal:  Neurochem Res       Date:  2014-11-28       Impact factor: 3.996

7.  Fos protein-like immunoreactive neurons induced by electrical stimulation in the trigeminal sensory nuclear complex of rats with chronically injured peripheral nerve.

Authors:  Naoko Fujisawa; Ryuji Terayama; Daisuke Yamaguchi; Shinji Omura; Takashi Yamashiro; Tomosada Sugimoto
Journal:  Exp Brain Res       Date:  2012-03-29       Impact factor: 1.972

8.  Partial infraorbital nerve ligation as a model of trigeminal nerve injury in the mouse: behavioral, neural, and glial reactions.

Authors:  Mei Xu; Megumi Aita; Charles Chavkin
Journal:  J Pain       Date:  2008-08-16       Impact factor: 5.820

9.  Increased phosphorylation of extracellular signal-regulated kinase in trigeminal nociceptive neurons following propofol administration in rats.

Authors:  Emi Shoda; Junichi Kitagawa; Ikuko Suzuki; Ieko Nitta-Kubota; Makiko Miyamoto; Yoshiyuki Tsuboi; Masahiro Kondo; Yuji Masuda; Yoshiyuki Oi; Ke Ren; Koichi Iwata
Journal:  J Pain       Date:  2009-04-23       Impact factor: 5.820

10.  A new model of experimental parotitis in rats and its implication for trigeminal nociception.

Authors:  A Ogawa; K Ren; Y Tsuboi; T Morimoto; T Sato; K Iwata
Journal:  Exp Brain Res       Date:  2003-07-31       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.